BioNTech SE (BNTX) Return on Sales (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Return on Sales data on file, last reported at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Sales slipped to 0.0% in Q4 2025, from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2021 to a low of 0.06% in Q2 2024.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales fell 5 bps in 2023 and gained 5 bps in 2025, its largest moves.
• Tracing BNTX's Return on Sales over 5 years: stood at 0.01% in 2021, then dropped by 16 bps to 0.01% in 2022, then tumbled by 38 bps to 0.01% in 2023, then slumped by 51 bps to 0.0% in 2024, then slumped by 157 bps to 0.0% in 2025.
• Business Quant data shows BNTX's Return on Sales at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.02% in Q2 2025.